Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
751.71M | 733.78M | 676.17M | 547.37M | 451.03M | 403.66M | Gross Profit |
288.05M | 275.61M | 233.56M | 198.34M | 162.44M | 144.76M | EBIT |
108.35M | 106.28M | 95.25M | 83.19M | 76.03M | 63.57M | EBITDA |
117.32M | 114.60M | 108.78M | 100.17M | 90.40M | 75.30M | Net Income Common Stockholders |
53.58M | 51.91M | 47.88M | 52.81M | 52.08M | 41.60M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
16.29M | 44.79M | 36.86M | 26.24M | 6.78M | 1.17M | Total Assets |
1.08B | 1.21B | 1.14B | 1.11B | 652.48M | 609.34M | Total Debt |
391.47M | 308.29M | 462.99M | 400.00M | 149.13M | 149.06M | Net Debt |
375.18M | 263.50M | 426.12M | 373.76M | 142.35M | 147.89M | Total Liabilities |
645.50M | 660.41M | 662.38M | 675.67M | 310.45M | 316.94M | Stockholders Equity |
433.03M | 505.18M | 438.93M | 431.59M | 342.02M | 292.40M |
Cash Flow | Free Cash Flow | ||||
89.69M | 51.41M | 22.41M | 36.02M | 22.12M | 27.43M | Operating Cash Flow |
100.43M | 61.58M | 31.71M | 50.59M | 44.41M | 40.60M | Investing Cash Flow |
-10.74M | -10.16M | -35.13M | -256.53M | -22.28M | -13.17M | Financing Cash Flow |
-84.07M | -45.43M | 14.04M | 225.41M | -16.51M | -26.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | C$1.52B | 28.36 | 11.64% | 2.31% | 12.62% | 47.37% | |
54 Neutral | $5.31B | 3.28 | -45.10% | 2.80% | 16.76% | 0.02% | |
$20.83M | ― | -16.89% | ― | ― | ― | ||
$3.72M | ― | -351.09% | ― | ― | ― | ||
$7.62M | ― | ― | ― | ― | |||
33 Underperform | C$1.87M | ― | -185.93% | ― | ― | 48.34% | |
27 Underperform | C$4.37M | ― | ― | -97.30% | 39.70% |
Jamieson Wellness Inc. announced the successful election of its nominee directors at the 2025 Annual Meeting of Shareholders, with all directors receiving overwhelming support. This development underscores the company’s stable governance and continued focus on expanding its market presence in the natural health industry.
The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.
Jamieson Wellness Inc. announced the redemption of its Series A Preference Shares held by DCP Capital Partners, reflecting a strategic financial move aligned with DCP’s investment cycle. This redemption underscores the successful partnership between Jamieson and DCP, which has significantly bolstered Jamieson’s presence in China’s VMS market, contributing to substantial growth and positioning the company for continued success in this critical market.
The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.
Jamieson Wellness Inc. reported a strong start to 2025 with a 14% increase in consolidated revenue for the first quarter, driven by significant growth in China and strategic initiatives in Canada and international markets. The company’s strategic focus on innovation, operational efficiency, and expanding market reach has resulted in increased gross profit margins and improved financial performance, despite a net loss. The growth in China was particularly notable, with a 52% revenue increase, highlighting the success of their tailored approach and strategic investments in the region.
Jamieson Wellness Inc. announced it will release its first quarter 2025 financial results on May 8, 2025, followed by a conference call for investors. This announcement is significant for stakeholders as it provides an opportunity to assess the company’s financial health and strategic direction, potentially impacting its market positioning and investor confidence.
Jamieson Wellness Inc. is hosting an Investor Day in Toronto on March 27, 2025, where senior management will present the company’s strategic vision and growth outlook to institutional investors and analysts. The event, which includes a live webcast and a Q&A session, aims to highlight Jamieson’s competitive market positioning and future plans, potentially impacting its operations and industry standing.